ConvaTec Group PLC (CNVVY)
13.40
+0.15
(+1.11%)
USD |
OTCM |
May 17, 15:45
ConvaTec Group Total Liabilities (Quarterly): 2.021B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.021B |
| June 30, 2023 | 2.127B |
| December 31, 2022 | 1.982B |
| June 30, 2022 | 2.102B |
| December 31, 2021 | 1.979B |
| June 30, 2021 | 2.032B |
| December 31, 2020 | 2.096B |
| June 30, 2020 | 2.053B |
| Date | Value |
|---|---|
| December 31, 2019 | 2.049B |
| June 30, 2019 | 2.130B |
| December 31, 2018 | 2.043B |
| June 30, 2018 | 2.242B |
| December 31, 2017 | 2.277B |
| June 30, 2017 | 2.291B |
| December 31, 2016 | 2.268B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.979B
Minimum
Dec 2021
2.130B
Maximum
Jun 2019
2.057B
Average
2.051B
Median
Total Liabilities (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 243.10M |
| Biodexa Pharmaceuticals Plc | 7.470M |
| Verona Pharma PLC | 64.92M |
| NuCana PLC | 16.46M |
| Autolus Therapeutics PLC | 263.91M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.714B |
| Shareholders Equity (Quarterly) | 1.693B |
| Debt to Equity Ratio | 0.7248 |
| Current Ratio | 1.622 |
| Net Debt Paydown Yield | 0.63% |